Document is current
Any future updates will be listed below
-
Authors
Nguyen, David N. https://orcid.org/0000-0001-6808-2717
Roth, Theodore L.
Li, P. Jonathan https://orcid.org/0000-0002-5204-6401
Chen, Peixin Amy
Apathy, Ryan
Mamedov, Murad R. https://orcid.org/0000-0002-1543-3330
Vo, Linda T.
Tobin, Victoria R.
Goodman, Daniel
Shifrut, Eric https://orcid.org/0000-0001-6827-0128
Bluestone, Jeffrey A. https://orcid.org/0000-0001-8793-7848
Puck, Jennifer M.
Szoka, Francis C. https://orcid.org/0000-0002-6236-0621
Marson, Alexander https://orcid.org/0000-0002-2734-5776
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Division of Loan Repayment (L40 AI140341)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (T32A1007641, DP3DK111914-01, R01DK1199979, P50GM082250)
CIS CSL Behring Fellowship Award
U.S. Department of Health & Human Services | National Institutes of Health (T32GM007618, T32 DK007418)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (F30DK120213)
W. M. Keck Foundation
Jeffrey Modell Foundation
National Multiple Sclerosis Society (CA 1074-A-21)
Burroughs Wellcome Fund
gifts from Jake Aronov and Barbara Bakar; American Endowment Foundation
- License Information
-
More Information
Article History
Received: 16 April 2019
Accepted: 25 October 2019
First Online: 9 December 2019
Competing interests
: A.M. is a co-founder of Spotlight Therapeutics. T.L.R. and A.M. are co-founders of ArsenalBio. J.A.B. is a founder of Sonoma Biotherapeutics. A.M. serves on the scientific advisory board of PACT Pharma, is an advisor to Trizell, and was a former advisor to Juno Therapeutics. The Marson laboratory has received sponsored research support from Juno Therapeutics, Epinomics, and Sanofi, as well as a gift from Gilead. Patents have been filed based on the findings described here. All other authors have no competing interests.
